Skip to main content
SpringerLink
Log in

Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid

  • Original Investigation
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Several hypolipidemic drugs, plasticizers, and other chemicals induce hepatic peroxisome proliferation and hepatocellular carcinomas in rodents. These agents induce and promote hepatocarcinogenesis by unknown mechanisms, since most studies have not found them to be genotoxic. Peroxisome proliferators increase the expression of several genes, including those for the enzymes of the peroxisomal β-oxidation path-way and the cytochrome P-450 4A family, which metabolize lipids, including eicosanoids and their precursor fatty acids. The peroxisome proliferators ciprofibrate and perfluorodecanoic acid (PFDA) were therefore examined for their ability to alter hepatic eicosanoid concentrations. Rats received injections of 3 or 10 mg PFDA/kg body weight every 14 days or were fed 0.01% ciprofibrate for 10 days, 24 days, 6 weeks, 26 weeks, or 54 weeks. The activity of the peroxisomal enzyme fatty acyl CoA oxidase was significantly increased by both ciprofibrate and PFDA at all times. Hepatic concentrations of prostaglandins E2 and F2α (PGE2, PGF2α) thromboxane B2 (TXB2), and leukotriene C4 (LTC4) were measured by immunoassay. Concentrations of PGE2, PGF2α, and TXB2 were decreased in livers of rats receiving ciprofibrate or PFDA compared to livers of control rats, with ciprofibrate exerting a greater effect than PFDA at the doses used. Hepatic LTC4 concentrations were significantly increased by ciprofibrate at 10 days and PFDA at 54 weeks, and significantly decreased by PFDA at 26 weeks. These alterations in eicosanoid concentrations may be important in the natural history of peroxisome proliferator-induced hepatocarcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bains SK, Gardiner SM, Mannweiler K, Gillett D, Gibson GG (1985) Immunochemical study on the contribution of hypolipidaemic-induced cytochrome P-452 to the metabolism of lauric acid and arachidonic acid. Biochem Pharmacol 34: 3221–3229

    Article  PubMed  CAS  Google Scholar 

  • Beer DG, Pitot HC (1987) Biological markers characterizing the development of preneoplastic and neoplastic lesions in rodent liver. Arch Toxicol Suppl. 10: 68–80

    PubMed  CAS  Google Scholar 

  • Bentley P, Calder I, Elcombe C, Grasso P, Stringer D, Wiegand HJ (1993) Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem Toxicol 31: 857–907

    Article  PubMed  CAS  Google Scholar 

  • Borges T, Glauert HP, Chen L-C, Chow CK, Robertson LW (1990) Effect of the peroxisome proliferator perfluorodecanoic acid on growth and lipid metabolism in Sprague Dawley rats fed three dietary levels of selenium. Arch Toxicol 64: 26–30

    Article  PubMed  CAS  Google Scholar 

  • Borges T, Robertson LW, Peterson RE, Glauert HP (1992) Doserelated effects of perfluorodecanoic acid on growth, feed intake and hepatic peroxisomal beta-oxidation. Arch Toxicol 66: 18–22

    Article  PubMed  CAS  Google Scholar 

  • Borges T, Glauert HP, Robertson LW (1993a) Perfluorodecanoic acid noncompetitively inhibits the peroxisomal enzymes enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase. Toxicol Appl Pharmacol 118: 8–15

    Article  PubMed  CAS  Google Scholar 

  • Borges T, Peterson RE, Pitot HC, Robertson LW, Glauert HP (1993b) Effect of the peroxisome proliferator perfluorodecanoic acid on the promotion of 2-stage hepatocarcinogenesis in rats. Cancer Lett 72: 111–120

    Article  PubMed  CAS  Google Scholar 

  • Brass EP, Ruff LJ (1991) Effect of clofibrate treatment on hepatic prostaglandin catabolism and action. J Pharmacol Exp Ther 257: 1034–1038

    PubMed  CAS  Google Scholar 

  • Capdevila JH, Falck JR, Estabrook RW (1992) Cytochrome-P450 and the arachidonate cascade. FASEB J 6: 731–736

    PubMed  CAS  Google Scholar 

  • Cayen MN (1983) Metabolism and pharmacokinetics of antihyperlipidaemic agents. Prog Drug Metab 7: 173–227

    CAS  Google Scholar 

  • Denda A, Ura H, Tsujiuchi T, Tsutsumi M, Eimoto H, Takashima Y, Kitazawa S, Kinugasa T, Konishi Y (1989) Possible involvement of arachidonic acid metabolism in phenobarbital promotion of hepatocarcinogenesis. Carcinogenesis 10: 1929–1935

    Article  PubMed  CAS  Google Scholar 

  • Diczfalusy U, Alexson SEH (1990) Identification of metabolites from peroxisomal β-oxidation of prostaglandins. J Lipid Res 31: 307–314

    PubMed  CAS  Google Scholar 

  • Diczfalusy U, Vesterqvist O, Kase BF, Lund E, Alexson SEH (1993) Peroxisomal chain-shortening of thromboxane B2—evidence for impaired degradation of thromboxane B2 in Zellweger syndrome. J Lipid Res 34: 1107–1113

    PubMed  CAS  Google Scholar 

  • Fischer SM, Fürstenberger G, Marks F, Slaga TJ (1987) Events associated with mouse skin tumor promotion with respect to arachidonic acid metabolism: a comparison between SENCAR and NMRI mice. Cancer Res 47: 3174–3179

    PubMed  CAS  Google Scholar 

  • Foxworthy PS, Perry DN, Eacho PI, (1993) Induction of peroxisomal beta-oxidation by nonsteroidal anti-inflammatory drugs. Toxicol Appl Pharmacol 118: 271–274

    Article  PubMed  CAS  Google Scholar 

  • George ME, Andersen ME (1986) Toxic effects of nonadecafluoro-,n-decanoic acid in rats. Toxicol Appl Pharmacol 85: 169–180

    Article  PubMed  CAS  Google Scholar 

  • Gill JL (1978) Design and Analysis of Experiments in the Animal and Medical Sciences, Volume 1. Iowa State University Press, Ames, Iowa

    Google Scholar 

  • Glauert HP, Beaty MM, Clark TD, Greenwell WS, Tatum V, Chen LC, Borges T, Clark TL, Srinivasan SR, Chow CK (1990) Effect of dietary vitamin E on the development of altered hepatic foci and hepatic tumors induced by the peroxisome proliferator ciprofibrate. J Cancer Res Clin Oncol 116: 351–356

    Article  PubMed  CAS  Google Scholar 

  • Gronn M, Christensen E, Hagve TA, Christophersen BO (1992) Effects of clofibrate feeding on essential fatty acid desaturation and oxidation in isolated rat liver cells. Biochim Biophys Acta 1123: 170–176

    PubMed  CAS  Google Scholar 

  • Gupta C, Banks M, Shinozuka H (1989) Elevated levels of prostaglandin E2 in the liver of rats fed a choline deficient diet: possible involvement in liver tumor promotion. Cancer Lett 46: 129–135

    Article  PubMed  CAS  Google Scholar 

  • Hawkins JM, Jones WE, Bonner FW, Gibson GG (1987) The effect of peroxisome proliferators on microsomal peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metab Rev 18: 441–515

    Article  PubMed  CAS  Google Scholar 

  • Hendrich S, Krueger SK, Chen HW, Cook L (1991) Phenobarbital increases rat hepatic prostaglandin F2α, glutathione-S-transferase activity, and oxidative stress. Prostaglandins Leukotrienes Essential Fatty Acids 42: 45–50

    Article  CAS  Google Scholar 

  • Huwyler J, Jedlitschky G, Keppler D, Gut J (1992) Halothane metabolism—impairment of hepatic omega-oxidation of leukotrienes in vivo and in vitro. Eur J Biochem 206: 869–879

    Article  PubMed  CAS  Google Scholar 

  • Jedlitschky G, Huber M, Völkl A, Müller M, Leier I, Müller J, Lehmann WD, Fahimi HD, Keppler D (1991) Peroxisomal degradation of leukotrienes by beta-oxidation from the omegaend. J Biol Chem 266: 24763–24772

    PubMed  CAS  Google Scholar 

  • Kawashima Y, Hirose A, Kozuka H (1984) Modification by clofibric acid of acyl composition of glycolipids in rat liver. Possible involvement of fatty acid chain elongation and desaturation. Biochim Biophys Acta 795: 543–551

    PubMed  CAS  Google Scholar 

  • Kawashima Y, Nishizawa H, Kozuka H (1992) Reduction by clofibric acid of serum arachidonic acid in rats—effect on the acyl composition of renal phospholipids. Biochem Pharmacol 43: 2321–2326

    Article  PubMed  CAS  Google Scholar 

  • Kupfer D (1980) Endogenous substrates of monooxygenases, fatty acids and prostaglandins. Pharmacol Ther 11: 469–496

    Article  PubMed  CAS  Google Scholar 

  • Lalwani ND, Reddy MK, Qureshi SA, Sirtori CR, Abiko Y, Reddy JK (1982) Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver. Hum Toxicol 2: 27–48

    Article  Google Scholar 

  • Lee PPH, Ip MM (1992) Regulation of proliferation of rat mammary tumor cells by inhibitors of cyclooxygenase and lipoxygenase. Prostaglandins Leukotrienes Essential Fatty Acids 45: 21–31

    Article  Google Scholar 

  • Lock EA, Mitchell AM, Elcombe CR (1989) Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu Rev Pharmacol Toxicol 29: 145–163

    Article  PubMed  CAS  Google Scholar 

  • Marnett LJ (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575–5589

    PubMed  CAS  Google Scholar 

  • Olson CT, Andersen ME (1983) The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and the effect on tissue fats. Toxicol Appl Pharmacol 70: 362–372

    Article  PubMed  CAS  Google Scholar 

  • Poosch MS, Yamazaki RK (1986) Determination of peroxisomal fatty acyl-CoA oxidase activity using a lauroyl-CoA-based fluorometric assay. Biochim Biophys Acta 884: 585–593

    PubMed  CAS  Google Scholar 

  • Powell WS (1982) Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. Methods Enzymol 86: 467–477

    Article  PubMed  CAS  Google Scholar 

  • Pradelles P, Grassi J, Maclouf J (1985) Enzyme immunoassay of eicosanoids using acetylcholinesterase as label: an alternative to radioimmunoassay. Anal Chem 57: 1170–1173

    Article  PubMed  CAS  Google Scholar 

  • Reddy JK, Lalwani ND (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit Rev Toxicol 12: 1–58

    Article  CAS  Google Scholar 

  • Skouteris GG, Ord MG, Stocken LA (1988) Regulation of the proliferation of primary rat hepatocytes by eicosanoids. J Cell Physiol 135: 516–520

    Article  PubMed  CAS  Google Scholar 

  • Tai HH, Yuan B (1978) Development of radioimmunoassay for thromboxane B2. Anal Biochem 87: 343–349

    Article  PubMed  CAS  Google Scholar 

  • Takahashi M, Furukawa F, Toyoda K, Sato H, Hasegawa R, Imaida K, Hayashi Y (1990) Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcino-genesis 11: 393–395

    Article  CAS  Google Scholar 

  • Tang Q, Denda A, Tsujiuchi T, Tsutsumi M, Amanuma T, Murata Y, Maruyama H, Konishi Y (1993) Inhibitory effects of inhibitors of arachidonic acid metabolism on the evolution of rat liver preneoplastic foci into nodules and hepatocellular carcinomas with or without phenobarbital exposure. Jpn J Cancer Res 84: 120–127

    PubMed  CAS  Google Scholar 

  • Vamecq J, Draye JP (1987) Interactions between the omega-and β-oxidations of fatty acids. J Biochem 102: 225–234

    PubMed  CAS  Google Scholar 

  • Vamecq J, Draye JP (1989) Peroxisomal and mitochondrial β-oxidation of monocarboxyl-CoA, omega-hydroxymonocarboxylyl-CoA and dicarboxylyl-CoA esters in tissues from untreated and clofibrate-treated rats. J Biochem 106: 216–222

    PubMed  CAS  Google Scholar 

  • Vanden Heuvel JP, Kuslikis BI, Van Rafelghem MJ, Peterson RE (1991) Disposition of perfluorodecanoic acid in male and female rats. Toxicol Appl Pharmacol 107: 450–459

    Article  Google Scholar 

  • Wickremasinghe RG (1988) The role of prostaglandin in the regulation of cell proliferation. Prostaglandins Leukotrienes Essential Fatty Acids 31: 171–179

    CAS  Google Scholar 

  • Willis AL (1987) The eicosanoids: an introduction and an overview. In: Willis AL (ed) CRC Handbook of Eicosanoids: Prostaglandins and Related Lipids, Volume 1. Chemical and Biochemical Aspects. CRC Press, Boca Raton, Fla. pp 3–46

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nutrition and Food Science, University of Kentucky, 219 Funkhouser Building, 40506-0054, Lexington, KY, USA

    Mary W. Wilson, L. Travis Lay, Ching K. Chow & Howard P. Glauert

  2. Graduate Center for Toxicology, University of Kentucky, 40506, Lexington, KY, USA

    Ching K. Chow, Larry W. Robertson & Howard P. Glauert

  3. College of Pharmacy, University of Kentucky, 40506, Lexington, KY, USA

    Hsin -Hsiung Tai

Authors
  1. Mary W. Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Travis Lay
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ching K. Chow
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hsin -Hsiung Tai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Larry W. Robertson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Howard P. Glauert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilson, M.W., Lay, L.T., Chow, C.K. et al. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Arch Toxicol 69, 491–497 (1995). https://doi.org/10.1007/s002040050203

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002040050203

Key words

Search

Navigation